Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6UFC

Carbonic anhydrase 2 with inhibitor (2Z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-N-(4-sulfamoylphenyl)butanamide (11d/D4)

Summary for 6UFC
Entry DOI10.2210/pdb6ufc/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, (2Z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-N-(4-sulfamoylphenyl)butanamide, ... (6 entities in total)
Functional Keywordscarbonic anhydrase, inhibitor, complex, lyase-lyase inhibitor complex, lyase/lyase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight29843.97
Authors
Peat, T.S. (deposition date: 2019-09-24, release date: 2020-08-05, Last modification date: 2023-10-11)
Primary citationFares, M.,Eldehna, W.M.,Bua, S.,Lanzi, C.,Lucarini, L.,Masini, E.,Peat, T.S.,Abdel-Aziz, H.A.,Nocentini, A.,Keller, P.A.,Supuran, C.T.
Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action.
J.Med.Chem., 63:3317-3326, 2020
Cited by
PubMed Abstract: The design of three dual-tailed sulfonamide series , , and as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors are presented. All compounds were evaluated for inhibitory action against pharmacologically relevant human CA isoforms I, II, IV, and VII. Compounds emerged as potent CA inhibitors against the four tested isoforms with a significant selectivity to CA II, which is implicated in glaucoma ( in the range 0.36-6.9 nM). X-ray crystallographic analysis of three compounds (, , and ) bound to CA II showed the validity of the adopted drug design strategy as specific moieties within the ligand structure interacted directly with the hydrophobic and hydrophilic halves of the CA II active site. Compounds - and were evaluated for their intraocular pressure-lowering effects in a rabbit model of glaucoma. and showed significant efficacy when compared to the clinically used drug dorzolamide.
PubMed: 32031797
DOI: 10.1021/acs.jmedchem.9b02090
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.325 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon